secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUPERNUS PHARMACEUTICALS, INC. (SUPN)
CIK:        0001356576
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001356576-25-000046
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supernus announces Q2 2025 earnings release and conference call on Aug 5, 2025
------------------------------------------------------------------------------

- Press release states Q2 2025 results will be reported after market close on August 5, 2025.
- Conference call with President/CEO Jack Khattar and CFO Tim Dec on August 5 at 4:30 p.m. ET.
- No preliminary financial results or guidance are provided in this announcement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/0001356576-25-000046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/supn-20250722.htm
  HTML page:      https://secwatch.observer/filing/0001356576-25-000046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer